SGMO Historical PE Ratio image   This SGMO PE ratio history page last updated 5/9/2022
SGMO Historical PE Ratio Chart
Data adjusted for SGMO split history

PeriodPriceGAAPAnnualizedPE
Q1 2022
5/5/2022
4.30-0.30-1.20NA
Q4 2021
2/24/2022
5.71-0.26-1.04NA
Q3 2021
11/4/2021
10.89-0.33-1.32NA
Q2 2021
8/5/2021
9.97-0.33-1.32NA
Q1 2021
5/4/2021
11.36-0.32-1.28NA
Q4 2020
2/24/2021
12.52-0.29-1.16NA
Q3 2020
11/4/2020
11.82-0.01-0.04NA
Q2 2020
8/5/2020
11.50-0.26-1.04NA
Q1 2020
5/11/2020
9.06-0.37-1.48NA
Q4 2019
2/28/2020
8.530.040.1653.3
Q3 2019
11/6/2019
9.46-0.24-0.96NA
Q2 2019
8/7/2019
12.17-0.26-1.04NA
Q1 2019
5/8/2019
11.31-0.41-1.64NA
Q4 2018
2/28/2019
9.01-0.18-0.72NA
Q3 2018
11/8/2018
13.62-0.13-0.52NA
Q2 2018
8/8/2018
13.80-0.17-0.68NA
Q1 2018
5/8/2018
14.65-0.23-0.92NA
Q4 2017
2/22/2018
25.40-0.15-0.60NA
Q3 2017
11/9/2017
12.30-0.15-0.60NA
Q2 2017
8/9/2017
8.45-0.17-0.68NA
Q1 2017
5/10/2017
4.35-0.23-0.92NA
Q4 2016
2/28/2017
4.55-0.14-0.56NA
Q3 2016
10/26/2016
3.75-0.27-1.08NA
Q2 2016
8/3/2016
6.84-0.38-1.52NA
Q1 2016
5/2/2016
6.48-0.23-0.92NA
Q4 2015
2/9/2016
5.46-0.20-0.80NA
Q3 2015
10/28/2015
7.14-0.13-0.52NA
Q2 2015
8/5/2015
9.24-0.17-0.68NA
Q1 2015
4/22/2015
14.37-0.08-0.32NA
Q4 2014
2/10/2015
12.67-0.06-0.24NA
Q3 2014
10/22/2014
10.34-0.11-0.44NA
Q2 2014
7/23/2014
13.08-0.10-0.40NA
Q1 2014
5/6/2014
12.92-0.12-0.48NA
Q4 2013
2/11/2014
19.56-0.13-0.52NA
Q3 2013
10/23/2013
10.61-0.11-0.44NA
Q2 2013
7/24/2013
9.22-0.10-0.40NA
Q1 2013
5/8/2013
7.87-0.13-0.52NA
Q4 2012
2/6/2013
9.42-0.07-0.28NA
Q3 2012
10/24/2012
5.68-0.11-0.44NA
Q2 2012
7/25/2012
4.95-0.11-0.44NA
Q1 2012
5/2/2012
4.46-0.14-0.56NA
SGMO PE History Chart
PeriodPriceGAAPTTMPE
Q1 2022
5/5/2022
4.30-0.30-1.22NA
Q4 2021
2/24/2022
5.71-0.26-1.24NA
Q3 2021
11/4/2021
10.89-0.33-1.27NA
Q2 2021
8/5/2021
9.97-0.33-0.95NA
Q1 2021
5/4/2021
11.36-0.32-0.88NA
Q4 2020
2/24/2021
12.52-0.29-0.93NA
Q3 2020
11/4/2020
11.82-0.01-0.60NA
Q2 2020
8/5/2020
11.50-0.26-0.83NA
Q1 2020
5/11/2020
9.06-0.37-0.83NA
Q4 2019
2/28/2020
8.530.04-0.87NA
Q3 2019
11/6/2019
9.46-0.24-1.09NA
Q2 2019
8/7/2019
12.17-0.26-0.98NA
Q1 2019
5/8/2019
11.31-0.41-0.89NA
Q4 2018
2/28/2019
9.01-0.18-0.71NA
Q3 2018
11/8/2018
13.62-0.13-0.68NA
Q2 2018
8/8/2018
13.80-0.17-0.70NA
Q1 2018
5/8/2018
14.65-0.23-0.70NA
Q4 2017
2/22/2018
25.40-0.15-0.70NA
Q3 2017
11/9/2017
12.30-0.15-0.69NA
Q2 2017
8/9/2017
8.45-0.17-0.81NA
Q1 2017
5/10/2017
4.35-0.23-1.02NA
Q4 2016
2/28/2017
4.55-0.14-1.02NA
Q3 2016
10/26/2016
3.75-0.27-1.08NA
Q2 2016
8/3/2016
6.84-0.38-0.94NA
Q1 2016
5/2/2016
6.48-0.23-0.73NA
Q4 2015
2/9/2016
5.46-0.20-0.58NA
Q3 2015
10/28/2015
7.14-0.13-0.44NA
Q2 2015
8/5/2015
9.24-0.17-0.42NA
Q1 2015
4/22/2015
14.37-0.08-0.35NA
Q4 2014
2/10/2015
12.67-0.06-0.39NA
Q3 2014
10/22/2014
10.34-0.11-0.46NA
Q2 2014
7/23/2014
13.08-0.10-0.46NA
Q1 2014
5/6/2014
12.92-0.12-0.46NA
Q4 2013
2/11/2014
19.56-0.13-0.47NA
Q3 2013
10/23/2013
10.61-0.11-0.41NA
Q2 2013
7/24/2013
9.22-0.10-0.41NA
Q1 2013
5/8/2013
7.87-0.13-0.42NA
Q4 2012
2/6/2013
9.42-0.07-0.43NA
Q3 2012
10/24/2012
5.68-0.11NANA
Q2 2012
7/25/2012
4.95-0.11NANA
Q1 2012
5/2/2012
4.46-0.14NANA
Quotes delayed 20 minutes

Email EnvelopeFree SGMO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Sangamo Therapeutics (SGMO) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

SGRY PE Ratio History
SGTX PE Ratio History
SHC PE Ratio History
SIBN PE Ratio History
SIEN PE Ratio History
SIGA PE Ratio History
SILK PE Ratio History
SINT PE Ratio History
SIOX PE Ratio History
SLDB PE Ratio History
How should the SGMO historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Sangamo Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this SGMO Historical PE Ratio page.

What is the average historical PE for SGMO based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The SGMO historical PE ratio using the annualized quarterly earnings method works out to 53.3.

What is the average historical PE for SGMO based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The SGMO historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the SGMO Historical PE Ratio information for Sangamo Therapeutics' stock. The average SGMO historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 53.3. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average SGMO historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this SGMO historical PE result, against the recent PE: when this page was posted on 5/6/2022, the most recent closing price for SGMO had been 4.14, and the most recent quarterly earnings result, annualized, was 0.16. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent SGMO PE on 5/6/2022 based on annualized quarterly EPS was 25.9. Based on SGMO's history, that recent PE is low relative to the historical average, with the recent PE 51.4% lower than the historical average PE across our data set for Sangamo Therapeutics.

For self directed investors doing their due diligence on SGMO or any other given stock, valuation analysis for SGMO can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Sangamo Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for SGMO. Thanks for visiting, and the next time you need to research SGMO Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Institutional Holders of TIXT, TRV shares outstanding history, CFLT Videos.

 

SGMO Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.